U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Fig 3

Fig 3. From: The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

Kaplan-Meier curves showing Breast Cancer Specific Survival (BCSS) of WRAP53 IHC staining of nucleus and cytoplasm in combination, A. in the test set and B. in the validation set. Numbers at risk are listed below each chart.

Laxmi Silwal-Pandit, et al. PLoS One. 2015;10(10):e0139965.
2.
Fig 1

Fig 1. Immunohistochemical staining patterns of WRAP53 in breast cancer.. From: The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

A. and B. Positive nucleus/positive cytoplasma, C. and D. positive nucleus/negative cytoplasma (with normal mammary epithelial cells), E. positive nucleus/negative cytoplasm (invasive lobular carcinoma), and F. negative nucleus/negative cytoplasm.

Laxmi Silwal-Pandit, et al. PLoS One. 2015;10(10):e0139965.
3.
Fig 2

Fig 2. From: The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

Kaplan-Meier curves showing Breast Cancer Specific Survival (BCSS) of WRAP53 IHC staining of nucleus and cytoplasm A. in the test set and B. in the validation set. C. BCSS of WRAP53 nuclear IHC staining in validation set categorized based on fraction of stained cells. 0: no tumor cells with distinct staining of the nucleus, 1: <5% of the cells stained, 2: 5–50% of the cells stained, 3: 50–75% of the cells stained, and 4: >75% of the cells stained. Numbers at risk are listed below each chart.

Laxmi Silwal-Pandit, et al. PLoS One. 2015;10(10):e0139965.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center